Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Jorge L. Armenteros"'
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 46:558-565
Objective: To evaluate the effects of risperidone augmentation for treatment-resistant aggression in children with attention-deficit/hyperactivity disorder (ADHD). Method: Twenty-five children (ages 7-12 years) with attention-deficit/hyperactivity di
Autor:
Huong Hew, John C. LeBlanc, Jorge L Armenteros, Michael G. Aman, Vivek Kusumakar, Jenny Wang, Carin Binder
Publikováno v:
International Clinical Psychopharmacology. 20:275-283
The present study aimed to analyse the effect of risperidone on a priori defined core aggression items. Data were pooled from 163 boys (aged 5-12 years, with or without comorbid attention-deficit/hyperactivity disorder) with a DSM-IV diagnosis of eit
Autor:
John E. Lewis, Jorge L. Armenteros
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 41:522-529
Objective To assess the short-term effect and safety of citalopram in the reduction of impulsive aggression in children and adolescents. Method Twelve subjects, aged 7 to 15 years, were attending a psychiatric outpatient clinic and had a profile of i
Autor:
Phillip B. Adams, Jeanette E. Cueva, Jorge L. Armenteros, Sanchez Le, Magda Campbell, Arthur M. Small
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 35:537-544
Objective To assess the short-term efficacy and safety of Clomipramine in hospitalized young children with autism. Method This was an open pilot study; after a 1-week placebo baseline, subjects were treated with Clomipramine for 5 weeks. Dosage was i
Autor:
Jorge L. Armenteros, Magda Campbell, Jeanette E. Cueva, John E. Overall, Richard Perry, Arthur M. Small
Publikováno v:
Journal of the American Academy of Child & Adolescent Psychiatry. 35:480-490
Objective To assess critically the short-term efficacy and safety of carbamazepine in the reduction of aggressiveness in children with diagnosed conduct disorder. Method Subjects were children aged 5 to 12 years who were hospitalized for treatment-re
Autor:
Mark Davies, Jorge L. Armenteros
Publikováno v:
European childadolescent psychiatry. 15(3)
To develop an evidence base for using antipsychotic medications for schizophrenia in children and adolescents. Data sources were identified in PsychINFO (1872–2003), MEDLINE (1966–2003), and articles in reference lists. Study selection criteria:
Autor:
Jorge L. Armenteros, Ashraf G. Mikhail
Publikováno v:
Psychopharmacology. 159(2)
Rationale: Ethical issues are raised when placebos are used in human experimentation. This ethical concern is accentuated when research is contemplated among special sub-groups such as children, especially if they suffer from schizophrenia. Objective
Autor:
Phillip Adams, Jorge L. Armenteros, Magda Campbell, Richard P. Malone, Zena Eisenberg, John E. Overall
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 36(6)
Objective To report results from a long-term prospective study of safety of haloperidol treatment and prevalence of haloperidol-related dyskinesias. Method Subjects were children with autism requiring pharmacotherapy for target symptoms. After baseli
Publikováno v:
Journal of the American Academy of Child and Adolescent Psychiatry. 36(5)
Objective To assess critically the short-term efficacy and safety of risperidone in adolescents with schizophrenia. Method Subjects were adolescents who were attending a research day hospital as outpatients and who had received a diagnosis of schizop
Publikováno v:
Journal of child and adolescent psychopharmacology. 7(3)
Dopamine receptor antagonists, particularly haloperidol, have been the most effective medications in currently available double-blind placebo-controlled studies for treating the disruptive behaviors often associated with pervasive developmental disor